Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Ketorolac × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1 Gastrointestinal 1 Endocrine 1

Conditions

Multiple Endocrine Neoplasia Type 1 1 Emergencies 1

Interventions

Eating 5 Standard of Care 4 Radiofrequency Ablation 4 Exercise 3 Endoscopic Mucosal Resection 3 lutetium Lu 177 dotatate 2 Yoga 2 Surgical Procedures, Operative 2 Saline Solution 2 Radiosurgery 2 Proton Therapy 2 Propofol 2 Palliative Care 2 Magnetic Resonance Imaging 2 Lutetium-177 2 Liquid Biopsy 2 Hydrocortisone 2 Diet, Mediterranean 2 Diet 2 Desflurane 2 Data Collection 2 Control Groups 2 Calcium 2 Adrenalectomy 2 3-Iodobenzylguanidine 2 ziprasidone 1 pentetreotide 1 penpulimab 1 pegfilgrastim 1 parecoxib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01471639 2025-08-15

Sprix

The Cleveland Clinic

Phase NA Completed

37 enrolled 7 charts

Emergencies, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡